Okay, let's tackle this question about pituitary tumors and medical therapy. The question is asking which type of pituitary tumor is most responsive to medical therapy. First, I need to recall the different types of pituitary tumors and their treatment options.

Pituitary tumors are classified based on the hormones they secrete. The main types include prolactinomas, growth hormone-secreting tumors (acromegaly), ACTH-secreting tumors (Cushing's disease), and TSH-secreting tumors. There are also non-functioning adenomas that don't secrete hormones.

Medical therapy for these tumors varies. Prolactinomas are typically treated with dopamine agonists like cabergoline or bromocriptine, which are very effective. They work by inhibiting prolactin secretion and shrinking the tumor. Growth hormone-secreting tumors might use somatostatin analogs (like octreotide) or dopamine agonists, but these aren't as effective as for prolactinomas. ACTH-secreting tumors might use ketoconazole or other agents, but again, not as effective. TSH-secreting tumors are rare and usually require surgery.

The key here is that prolactinomas are the most responsive to medical therapy. The options given in the question are A to D, but the correct answer is prolactinoma. The other options (like growth hormone or ACTH-secreting tumors) are less responsive. The clinical pearl here is that dopamine agonists are first-line for prolactinomas, making them the most treatable with medication.

**Core Concept**
Pituitary tumors are classified by hormone secretion, with prolactin-secreting (prolactinomas) and growth hormone-secreting tumors being the most common. Medical therapy efficacy varies by tumor type due to differing hormonal mechanisms and receptor availability.

**Why the Correct Answer is Right**
Prolactinomas are most responsive to dopamine agonists like cabergoline or bromocriptine. These drugs inhibit prolactin release via **dopamine D2 receptors** on lactotrophs, reduce tumor size, and normalize hormone levels in >90% of cases. Their high responsiveness is due to the **direct dopaminergic regulation** of prolactin secretion, making medical therapy first-line.

**Why Each Wrong Option is Incorrect**
**Option A:** Growth hormone-secreting tumors respond poorly to dopamine agonists; somatostatin analogs (octreotide) are less effective.
**Option B:** ACTH-secreting tumors (Cushing’s disease) require transsphenoidal surgery or adrenocorticolytic drugs, not medical shrinkage.
**Option C:** Non-functioning adenomas lack hormonal targets, so medical therapy is ineffective.

**Clinical Pearl / High-Yield Fact**
**Prolactinomas are the only pituitary tumors routinely treated with medical therapy due to dopamine receptor expression.** Remember: *“Dopamine agonists shrink prolactinomas, not other tumors.”* USMLE/NEET often test this distinction.

**Correct Answer: C. Prolactinoma**

✓ Correct Answer: C. Prolactinoma